Zenith® Dissection Clinical Trial

ClinicalTrials.gov ID: NCT01568320

Public ClinicalTrials.gov record NCT01568320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Use of the Zenith® Dissection Endovascular System in the Treatment of Patients With Acute, Complicated Type B Aortic Dissection

Study identification

NCT ID: NCT01568320
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Cook Research Incorporated; Industry
Enrollment: 73 participants

Conditions and interventions

Conditions

Aortic Dissection

Interventions

Endovascular Treatment (Zenith) Device

Device

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 31, 2012
Primary completion: Jan 31, 2015
Completion: Jan 26, 2020
Last update posted: Mar 15, 2021

2012 – 2020

United States locations

U.S. sites: 23
U.S. states: 15
U.S. cities: 21

Facility	City	State	ZIP	Site status
Cedars-Sinai Medical Center	Los Angeles	California	90048	—
University of Florida	Gainesville	Florida	32610	—
University of South Florida	Tampa	Florida	33606	—
Indiana Heart Hospital	Indianapolis	Indiana	46250	—
Massachusetts General Hospital	Boston	Massachusetts	02114	—
Beth Israel Deaconess Medical Center	Boston	Massachusetts	02215	—
University of Massachusetts	Worcester	Massachusetts	01655	—
University of Michigan Hospital	Ann Arbor	Michigan	48109	—
Barnes-Jewish Hospital	St Louis	Missouri	63110	—
Dartmouth Hitchcock Medical Center	Lebanon	New Hampshire	03756	—
Cooper University Hospital	Camden	New Jersey	08103	—
Hackensack University Medical Center	Hackensack	New Jersey	07601	—
New York University Hospital	New York	New York	10016	—
Duke University Medical Center	Durham	North Carolina	27710	—
The Christ Hospital	Cincinnati	Ohio	45219	—
Hospital of the University of Pennsylvania	Philadelphia	Pennsylvania	19104	—
Allegheny General Hospital	Pittsburgh	Pennsylvania	15212	—
University of Pittsburgh Medical Center	Pittsburgh	Pennsylvania	15213	—
The Methodist Hospital	Houston	Texas	77030	—
Scott and White Hospital	Temple	Texas	76508	—
University of Virginia Medical Center	Charlottesville	Virginia	22908	—
Sentara Vascular Specialists	Norfolk	Virginia	23507	—
University of Washington-Harborview Medical Center	Seattle	Washington	98104	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01568320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 15, 2021 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01568320 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →